Evidence map›Paper›PMID 26838732›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2016

β3-adrenoceptor impacts apoptosis in cultured cardiomyocytes via activation of PI3K/Akt and p38MAPK.

Miao-Miao Ma, Xiao-Li Zhu, Li Wang, Xiao-Fang Hu, Zhong Wang, Jin Zhao, Yi-Tong Ma, Yi-Ning Yang, Bang-Dang Chen, Fen Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Miao-Miao MaDepartment of Cardiology, the First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832008, China.
Xiao-Li ZhuDepartment of Cardiology, the First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832008, China.
Li WangDepartment of Cardiology, the First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832008, China. mcmwl@163.com.
Xiao-Fang HuDepartment of Cardiology, the First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832008, China.
Zhong WangDepartment of Cardiology, the First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, 832008, China.
Jin ZhaoDepartment of Pathology, School of Medicine, Shihezi University, Shihezi, 832008, China.
Yi-Tong MaHeart Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Yi-Ning YangHeart Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Bang-Dang ChenHeart Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Fen LiuHeart Centre, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Shihezi University · CNFirst Affiliated Hospital of Xinjiang Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β3-adrenoceptor (β3-AR) has been shown to promote myocardial apoptosis. However, the exact physiological role and importance of this receptor in the human myocardium, and its underlying mode of action, have not been fully elucidated. The present study aimed to determine the effects of β3-AR on the promotion of myocardial apoptosis and on norepinephrine (NE) injury. We analyzed NE-induced cardiomyocyte (CM) apoptosis by using a TUNEL and an annexin V/propidium iodide apoptosis assay. Furthermore, we investigated the NE-induced expression of the apoptosis marker genes Akt and p38MAPK, their phosphorylated counterparts p-Akt and p-p38MAPK, caspase-3, Bcl-2, and Bax. In addition, we determined the effect of a 48-h treatment with a β3-AR agonist and antagonist on expression of these marker genes. β3-AR overexpression was found to increase CM apoptosis, accompanied by an increased expression of caspase-3, bax/bcl-2, and p-p38MAPK. In contrast, the β3-blocker reduced apoptosis of CMs and the associated elevated Akt expression. We identified a novel and potent anti-apoptosis mechanism via the PI3K/Akt pathway and a pro-apoptosis pathway mediated by p38MAPK.

Indexed as

ApoptosisAdrenergic AgonistsAdrenergic AntagonistsAnimalsCells, CulturedMyocytes, Cardiacp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyReceptors, Adrenergic, beta-3Signal TransductionAdrenergic AgonistsAdrenergic Antagonistsp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, Adrenergic, beta-3Aktapoptosiscardiomyocytesnorepinephrinep38MAPKβ3-adrenoreceptor

Identifiers

PMID26838732
OpenAlexW2414635268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.